Non Invasive Measurement of Coagulation in Term and Preterm Neonates

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2010 by Meir Medical Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Meir Medical Center
ClinicalTrials.gov Identifier:
NCT01167660
First received: July 5, 2010
Last updated: February 11, 2013
Last verified: June 2010
  Purpose

The purpose of this study is to assess the reliability of a new non-invasive device to assess the blood coagulation status among term and preterm babies.


Condition Intervention
Blood Coagulation Tests
Device: The Thrombo-Monitor (ThM)

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Non Invasive Measurement of Coagulation in Term and Preterm Neonates

Further study details as provided by Meir Medical Center:

Primary Outcome Measures:
  • Reliability of the non-invasive ThM device. [ Time Frame: From birth up to 1 month ] [ Designated as safety issue: No ]

Estimated Enrollment: 120
Study Start Date: July 2010
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Healthy newborn babies
Healthy newborn babies immediately after birth.
Device: The Thrombo-Monitor (ThM)
Non-invasive measurement of coagulation status and comparison to standard blood coagulation tests. In healthy neonates - immediately after birth, before the administration of vitamin K. Coagulation tests will be done on an umbilical cord blood sample. In sick neonates, coagulation studies will be done according to the medical condition.
Sick newborn babies
Sick newborn babies whose medical condition indicates performing coagulation tests.
Device: The Thrombo-Monitor (ThM)
Non-invasive measurement of coagulation status and comparison to standard blood coagulation tests. In healthy neonates - immediately after birth, before the administration of vitamin K. Coagulation tests will be done on an umbilical cord blood sample. In sick neonates, coagulation studies will be done according to the medical condition.

Detailed Description:

Coagulation abnormalities among neonates aren't common - but can be life threatening. Testing the coagulation system in small babies involves drawing significant amounts of blood (especially in premature babies). Non-invasive testing can help assess and treat term and preterm neonates at risk. Recently, a non-invasive device to assess the blood coagulation status was developed - The Thrombo-Monitor (ThM). The objective of this study is to assess the reliability of this new non-invasive device among term and preterm babies by comparing the result of the ThM reading to coagulation analysis from blood.

  Eligibility

Ages Eligible for Study:   up to 2 Months
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Term and preterm babies born in Meir Medical Center

Criteria

Inclusion Criteria:

  • Newborn babies - term and preterm
  • Written parental informed consent

Exclusion Criteria:

  • Congenital anomalies / chromosomal abnormalities
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01167660

Contacts
Contact: Ita Litmanovitz, MD +972-9-7471554 litmani@clalit.org.il
Contact: Gisela Laura Sirota, MD +972-9-7471554 gisela.sirota@clalit.org.il

Locations
Israel
Meir Medical Center Recruiting
Kfar-Saba, Israel
Contact: Ita Litmanovitz Litmanovitz, MD    09-7471554    litmani@clalit.org.il   
Principal Investigator: Ita Litmanovits, MD         
Sponsors and Collaborators
Meir Medical Center
Investigators
Principal Investigator: Ita Litmanovitz, MD Meir Medical Center
  More Information

No publications provided

Responsible Party: Meir Medical Center
ClinicalTrials.gov Identifier: NCT01167660     History of Changes
Other Study ID Numbers: Pag-ThM2
Study First Received: July 5, 2010
Last Updated: February 11, 2013
Health Authority: Israel: Ministry of Health

Keywords provided by Meir Medical Center:
Coagulation tests
Neonates
Non invasive

ClinicalTrials.gov processed this record on September 18, 2014